Endothelin A receptor blockade reduces diabetic renal injury via an anti-inflammatory mechanism

Jennifer M. Sasser, Jennifer C Sullivan, Janet L. Hobbs, Tatsuo Yamamoto, David M. Pollock, Pamela K. Carmines, Jennifer S. Pollock

Research output: Contribution to journalArticle

126 Citations (Scopus)

Abstract

Endothelin (ET) receptor blockade delays the progression of diabetic nephropathy; however, the mechanism of this protection is unknown. Therefore, the aim of this study was to test the hypothesis that ETA receptor blockade attenuates superoxide production and inflammation in the kidney of diabetic rats. Diabetes was induced by streptozotocin (diabetic rats with partial insulin replacement to maintain modest hyperglycemia [HG]), and sham rats received vehicle treatments. Some rats also received the ETA antagonist ABT-627 (sham+ABT and HG+ABT; 5 g/kg per d; n = 8 to 10/group). During the 10-wk study, urinary microalbumin was increased in HG rats, and this effect was prevented by ETA receptor blockade. Indices of oxidative stress, urinary excretion of thiobarbituric acid reactive substances, 8-hydroxy-2-deoxyguanosine, and H2O2 and plasma thiobarbituric acid reactive substances were significantly greater in HG rats than in sham rats. These effects were not prevented by ABT-627. In addition, renal cortical expression of 8-hydroxy-2-deoxyguanosine and NADPH oxidase subunits was not different between HG and HG+ABT rats. ETA receptor blockade attenuated increases in macrophage infiltration and urinary excretion of TGF-β and prostaglandin E2 metabolites in HG rats. Although ABT-627 did not alleviate oxidative stress in HG rats, inflammation and production of inflammatory mediators were reduced in association with prevention of microalbuminuria. These observations indicate that ETA receptor activation mediates renal inflammation and TGF-β production in diabetes and are consistent with the postulate that ETA blockade slows progression of diabetic nephropathy via an anti-inflammatory mechanism.

Original languageEnglish (US)
Pages (from-to)143-154
Number of pages12
JournalJournal of the American Society of Nephrology
Volume18
Issue number1
DOIs
StatePublished - Jan 1 2007

Fingerprint

Endothelin A Receptors
Anti-Inflammatory Agents
Hyperglycemia
Kidney
Wounds and Injuries
Thiobarbituric Acid Reactive Substances
Diabetic Nephropathies
Inflammation
Oxidative Stress
Endothelin Receptors
NADPH Oxidase
Streptozocin
Dinoprostone
Superoxides
Macrophages
Insulin

ASJC Scopus subject areas

  • Nephrology

Cite this

Endothelin A receptor blockade reduces diabetic renal injury via an anti-inflammatory mechanism. / Sasser, Jennifer M.; Sullivan, Jennifer C; Hobbs, Janet L.; Yamamoto, Tatsuo; Pollock, David M.; Carmines, Pamela K.; Pollock, Jennifer S.

In: Journal of the American Society of Nephrology, Vol. 18, No. 1, 01.01.2007, p. 143-154.

Research output: Contribution to journalArticle

Sasser, Jennifer M. ; Sullivan, Jennifer C ; Hobbs, Janet L. ; Yamamoto, Tatsuo ; Pollock, David M. ; Carmines, Pamela K. ; Pollock, Jennifer S. / Endothelin A receptor blockade reduces diabetic renal injury via an anti-inflammatory mechanism. In: Journal of the American Society of Nephrology. 2007 ; Vol. 18, No. 1. pp. 143-154.
@article{0880ce89f10c47ae9760308b584c35ef,
title = "Endothelin A receptor blockade reduces diabetic renal injury via an anti-inflammatory mechanism",
abstract = "Endothelin (ET) receptor blockade delays the progression of diabetic nephropathy; however, the mechanism of this protection is unknown. Therefore, the aim of this study was to test the hypothesis that ETA receptor blockade attenuates superoxide production and inflammation in the kidney of diabetic rats. Diabetes was induced by streptozotocin (diabetic rats with partial insulin replacement to maintain modest hyperglycemia [HG]), and sham rats received vehicle treatments. Some rats also received the ETA antagonist ABT-627 (sham+ABT and HG+ABT; 5 g/kg per d; n = 8 to 10/group). During the 10-wk study, urinary microalbumin was increased in HG rats, and this effect was prevented by ETA receptor blockade. Indices of oxidative stress, urinary excretion of thiobarbituric acid reactive substances, 8-hydroxy-2-deoxyguanosine, and H2O2 and plasma thiobarbituric acid reactive substances were significantly greater in HG rats than in sham rats. These effects were not prevented by ABT-627. In addition, renal cortical expression of 8-hydroxy-2-deoxyguanosine and NADPH oxidase subunits was not different between HG and HG+ABT rats. ETA receptor blockade attenuated increases in macrophage infiltration and urinary excretion of TGF-β and prostaglandin E2 metabolites in HG rats. Although ABT-627 did not alleviate oxidative stress in HG rats, inflammation and production of inflammatory mediators were reduced in association with prevention of microalbuminuria. These observations indicate that ETA receptor activation mediates renal inflammation and TGF-β production in diabetes and are consistent with the postulate that ETA blockade slows progression of diabetic nephropathy via an anti-inflammatory mechanism.",
author = "Sasser, {Jennifer M.} and Sullivan, {Jennifer C} and Hobbs, {Janet L.} and Tatsuo Yamamoto and Pollock, {David M.} and Carmines, {Pamela K.} and Pollock, {Jennifer S.}",
year = "2007",
month = "1",
day = "1",
doi = "10.1681/ASN.2006030208",
language = "English (US)",
volume = "18",
pages = "143--154",
journal = "Journal of the American Society of Nephrology : JASN",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "1",

}

TY - JOUR

T1 - Endothelin A receptor blockade reduces diabetic renal injury via an anti-inflammatory mechanism

AU - Sasser, Jennifer M.

AU - Sullivan, Jennifer C

AU - Hobbs, Janet L.

AU - Yamamoto, Tatsuo

AU - Pollock, David M.

AU - Carmines, Pamela K.

AU - Pollock, Jennifer S.

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Endothelin (ET) receptor blockade delays the progression of diabetic nephropathy; however, the mechanism of this protection is unknown. Therefore, the aim of this study was to test the hypothesis that ETA receptor blockade attenuates superoxide production and inflammation in the kidney of diabetic rats. Diabetes was induced by streptozotocin (diabetic rats with partial insulin replacement to maintain modest hyperglycemia [HG]), and sham rats received vehicle treatments. Some rats also received the ETA antagonist ABT-627 (sham+ABT and HG+ABT; 5 g/kg per d; n = 8 to 10/group). During the 10-wk study, urinary microalbumin was increased in HG rats, and this effect was prevented by ETA receptor blockade. Indices of oxidative stress, urinary excretion of thiobarbituric acid reactive substances, 8-hydroxy-2-deoxyguanosine, and H2O2 and plasma thiobarbituric acid reactive substances were significantly greater in HG rats than in sham rats. These effects were not prevented by ABT-627. In addition, renal cortical expression of 8-hydroxy-2-deoxyguanosine and NADPH oxidase subunits was not different between HG and HG+ABT rats. ETA receptor blockade attenuated increases in macrophage infiltration and urinary excretion of TGF-β and prostaglandin E2 metabolites in HG rats. Although ABT-627 did not alleviate oxidative stress in HG rats, inflammation and production of inflammatory mediators were reduced in association with prevention of microalbuminuria. These observations indicate that ETA receptor activation mediates renal inflammation and TGF-β production in diabetes and are consistent with the postulate that ETA blockade slows progression of diabetic nephropathy via an anti-inflammatory mechanism.

AB - Endothelin (ET) receptor blockade delays the progression of diabetic nephropathy; however, the mechanism of this protection is unknown. Therefore, the aim of this study was to test the hypothesis that ETA receptor blockade attenuates superoxide production and inflammation in the kidney of diabetic rats. Diabetes was induced by streptozotocin (diabetic rats with partial insulin replacement to maintain modest hyperglycemia [HG]), and sham rats received vehicle treatments. Some rats also received the ETA antagonist ABT-627 (sham+ABT and HG+ABT; 5 g/kg per d; n = 8 to 10/group). During the 10-wk study, urinary microalbumin was increased in HG rats, and this effect was prevented by ETA receptor blockade. Indices of oxidative stress, urinary excretion of thiobarbituric acid reactive substances, 8-hydroxy-2-deoxyguanosine, and H2O2 and plasma thiobarbituric acid reactive substances were significantly greater in HG rats than in sham rats. These effects were not prevented by ABT-627. In addition, renal cortical expression of 8-hydroxy-2-deoxyguanosine and NADPH oxidase subunits was not different between HG and HG+ABT rats. ETA receptor blockade attenuated increases in macrophage infiltration and urinary excretion of TGF-β and prostaglandin E2 metabolites in HG rats. Although ABT-627 did not alleviate oxidative stress in HG rats, inflammation and production of inflammatory mediators were reduced in association with prevention of microalbuminuria. These observations indicate that ETA receptor activation mediates renal inflammation and TGF-β production in diabetes and are consistent with the postulate that ETA blockade slows progression of diabetic nephropathy via an anti-inflammatory mechanism.

UR - http://www.scopus.com/inward/record.url?scp=33845979878&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845979878&partnerID=8YFLogxK

U2 - 10.1681/ASN.2006030208

DO - 10.1681/ASN.2006030208

M3 - Article

C2 - 17167119

AN - SCOPUS:33845979878

VL - 18

SP - 143

EP - 154

JO - Journal of the American Society of Nephrology : JASN

JF - Journal of the American Society of Nephrology : JASN

SN - 1046-6673

IS - 1

ER -